Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 19, 2022JAMA Network OpenOpen Access

Identification of Drug Interaction Adverse Events in Patients With COVID-19

View Full Paper
Ask AI
Bookmark
Share

Authors

VCValeria ContiUniversity of SalernoCSCarmine SellittoUniversity of SalernoMTMartina TorsielloUniversity of Campania "Luigi Vanvitelli"

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Conti et al. (2022) studied this question.

synapsesocial.com/papers/6a8c0b4198aeeda2ff893222https://doi.org/10.1001/jamanetworkopen.2022.7970
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients2020 · 920 citations
  2. 2High rate of major drug–drug interactions of lopinavir–ritonavir for COVID-19 treatment2020 · 22 citations